beta
Trial Radar AI
Clinical Trial NCT07502209 (SUPRA-PRF) for Chronic Shoulder Pain, Rotator Cuff Tendinopathy is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Suprascapular Nerve PRF in Chronic Shoulder Pain (SUPRA-PRF) 32

Not yet recruiting
Clinical Trial NCT07502209 (SUPRA-PRF) is an interventional study for Chronic Shoulder Pain, Rotator Cuff Tendinopathy and is currently not yet recruiting. Enrollment is planned to begin on April 10, 2026 and continue until the study accrues 32 participants. Led by Ankara City Hospital Bilkent, this study is expected to complete by August 30, 2027. The latest data from ClinicalTrials.gov was last updated on March 30, 2026.
Brief Summary
This study aims to compare the effects of pulsed radiofrequency (PRF) treatment of the suprascapular nerve using suprascapular notch and midpoint approaches on pain, shoulder function, and muscle strength in patients with chronic shoulder pain due to rotator cuff tendinopathy. Patients will be randomly assigned to one of the two intervention groups. Clinical evaluations will include pain assessment using the Numeric ...Show More
Detailed Description
Chronic shoulder pain is a common musculoskeletal condition that significantly affects daily activities and quality of life. Rotator cuff tendinopathy is one of the most frequent causes of chronic shoulder pain. The suprascapular nerve plays a key role in shoulder pain transmission, and pulsed radiofrequency (PRF) of the suprascapular nerve has emerged as an effective minimally invasive treatment option.

Different a...

Show More
Official Title

Comparison of Suprascapular Notch and Midpoint Approaches in Pulsed Radiofrequency Treatment of the Suprascapular Nerve on Pain and Function in Patients With Chronic Shoulder Pain

Conditions
Chronic Shoulder PainRotator Cuff Tendinopathy
Publications
Scientific articles and research papers published about this clinical trial:
Other Study IDs
  • SUPRA-PRF
  • TABED 1-26-2295
  • TABED 1-26-2295 (Other Identifier) (Ethics Committee of Ankara Bilkent City Hospital)
NCT ID Number
NCT07502209
Start Date (Actual)
2026-04-10
Last Update Posted
2026-03-30
Completion Date (Estimated)
2027-08-30
Enrollment (Estimated)
32
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
Suprascapular Nerve
Pulsed Radiofrequency
Chronic Shoulder Pain
Rotator Cuff Tendinopathy
Isokinetic Muscle Strength
Ultrasound Measurement
Shoulder Function
Primary Purpose
Treatment
Design Allocation
Randomized
Interventional Model
Parallel
Masking
Double
Arms / Interventions
Participant Group/ArmIntervention/Treatment
ExperimentalSuprascapular Notch PRF
Participants in this group will receive pulsed radiofrequency treatment of the suprascapular nerve via the suprascapular notch approach under ultrasound guidance.
PRF of the Suprascapular Nerve (Notch Approach)
Pulsed radiofrequency treatment will be applied to the suprascapular nerve via the suprascapular notch approach under ultrasound guidance using standard clinical parameters.
ExperimentalMidpoint PRF
Participants in this group will receive pulsed radiofrequency treatment of the suprascapular nerve via the midpoint approach under ultrasound guidance.
PRF of the Suprascapular Nerve (Midpoint Approach)
Pulsed radiofrequency treatment will be applied to the suprascapular nerve via the midpoint approach under ultrasound guidance using standard clinical parameters.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Isokinetic Shoulder Abduction Peak Torque
Isokinetic peak torque of shoulder abduction will be measured using an isokinetic dynamometer (ISOMED 2000). Measurements will be performed to evaluate changes in muscle strength.
Baseline and 3 months
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Pain Intensity (NPRS)
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), ranging from 0 (no pain) to 10 (worst imaginable pain).
Baseline, 24 hours, 1 month, and 3 months
Shoulder Function (SPADI)
Shoulder Pain and Disability Index (SPADI) will be used to assess pain and functional status.
Baseline, 1 month, and 3 months
Supraspinatus and Infraspinatus Muscle Thickness
Muscle thickness will be measured using ultrasonography to evaluate structural changes in the rotator cuff muscles.
Baseline and 3 months
Shoulder Range of Motion (ROM)
Shoulder joint range of motion will be measured using a goniometer.
Baseline and 3 months
Quality of Life (SF-36)
Health-related quality of life will be assessed using the Short Form-36 questionnaire (SF-36).
Baseline and 3 months
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
40 Years
Eligible Sexes
All
  • Patients aged between 40 and 80 years
  • Patients with chronic shoulder pain lasting longer than 3 months
  • Patients diagnosed with rotator cuff-related shoulder pain
  • Patients who show at least 50% pain reduction after diagnostic suprascapular nerve block
  • Patients who provide written informed consent

  • Adhesive capsulitis
  • Previous shoulder surgery
  • Full-thickness rotator cuff tear
  • Neurological disorders affecting the shoulder
  • Pacemaker
  • Coagulopathy or anticoagulant therapy contraindicating intervention
  • Infection at the injection site
  • Severe systemic disease
  • Pregnancy
  • Inability to comply with study protocol
Ankara City Hospital Bilkent logoAnkara City Hospital Bilkent
Study Responsible Party
Ayşe Merve Ata, Principal Investigator, Principal Investigator, Ankara City Hospital Bilkent
Study Central Contact
Contact: Gülberk Özok, MD, 5325034077, [email protected]
1 Study Locations in 1 Countries
Ankara Bilkent City Hospital, Ankara, 06800, Turkey (Türkiye)
Gülberk Özok, MD, Contact, 5325034077, [email protected]
Contact, [email protected]
Gülberk Özok, MD, Sub-Investigator